2X Blend Tesamorelin (10mg) / Ipamorelin (5mg) oral Tesamorelin specifically targets visceral fat

Tesamorelin specifically targets visceral fat loss while improving lipid metabolism

GHK-Cu Sublingual Strips feature GHK-Cu (3 mg per strip) in a fast-dissolving format

and metabolic signaling characterization strictly within laboratory settings

mobility enhancement

Intended research use

2X Blend Tesamorelin (10mg) / Ipamorelin (5mg) oral Tesamorelin specifically targets visceral fatA powerful blend of Tesamorelin (10mg) and Ipamorelin (5mg) designed to promote growth hormone (GH) release, supporting fat loss, muscle growth, and improved metabolic function. Tesamorelin, a growth hormone releasing factor (GHRF) analog, stimulates natural GH production, specifically targeting visceral fat reduction and improved lipid profiles. Ipamorelin selectively activates the ghrelin receptor, triggering a potent GH release while minimizing